Fingerprint
Dive into the research topics of 'Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically